Spreads in senior tranches are close to pre-crisis levels, banks are buying securitisations again and the regulators are hinting at a reprieve for ABS. Are we at the start of a genuine rehabilitation of the European product? Joe McDevitt reports.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.